Inventor · disambiguated record
Helmut Ensinger
Also filed as: ENSINGER HELMUT
23 granted patents·521 citations·filing 1985–2003
96Inventor score
Top patents by PatentIndex Score
23 records- 0194US5641784A8-substituted 1,3-dialiphaticxanthine derivativesBOEHRINGER INGELHEIM KG·Filed 1994·Granted Jun 24, 1997·69 cites·11 claims
- 0292US5719279AAsymmetrically substituted xanthinesBOEHRINGER INGELHEIM KG·Filed 1996·Granted Feb 17, 1998·140 cites·9 claims
- 0392US5240933A14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphine and -norisomorphine, processes for the preparation thereof and the use thereof as pharmaceutical compositionsBOEHRINGER SOHN INGELHEIM·Filed 1992·Granted Aug 31, 1993·54 cites·6 claims
- 0491US5286864AQuinuclidines, their use as medicaments and processes for their preparationBOEHRINGER INGELHEIM KG·Filed 1992·Granted Feb 15, 1994·47 cites·1 claims
- 0589US5532368AXanthine derivatives with adenosine-antagonistic activityBOEHRINGER SOHN INGELHEIM·Filed 1993·Granted Jul 2, 1996·53 cites·2 claims
- 0673US5451587AQuinuclidines, their use as medicaments and processes for their preparationBOEHRINGER SOHN INGELHEIM·Filed 1994·Granted Sep 19, 1995·22 cites·8 claims
- 0772US6770636B2Phenyl-and phenylalkyl-substituted ethanolamines and ethylenediaminesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Aug 3, 2004·5 cites·29 claims
- 0872US5731318ABenzomorphan derivativesBOEHRINGER INGELHEIM KG·Filed 1996·Granted Mar 24, 1998·15 cites·5 claims
- 0970US5508405AQuinuclidines, their use as medicaments and processes for their preparationBOEHRINGER SOHN INGELHEIM·Filed 1995·Granted Apr 16, 1996·23 cites·1 claims
- 1069US6441237B1Substituted 3-phenoxy- and 3-phenylalkyloxy-2-phenyl-propylaminesBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Aug 27, 2002·5 cites·10 claims
- 1169US6277872B1Oxadiazoles, processes for their preparation and their use as medicamentsBOEHRINGER INGELHEIM KG·Filed 1997·Granted Aug 21, 2001·33 cites·8 claims
- 1268US4670456A4-Aminocarbonylaminomethyl-1-benzylpyrrolidin-2-ones as nootropic agents and as agents for treating cerebral insufficiencyBOEHRINGER INGELHEIM KG·Filed 1985·Granted Jun 2, 1987·10 cites·6 claims
- 1364US4732900A1,2,4-triazolo-carbamatesBOEHRINGER INGELHEIM KG·Filed 1985·Granted Mar 22, 1988·12 cites·10 claims
- 1463US5696124AXanthine derivatives with adenosine-antagonistic activityBOEHRINGER INGELHEIM KG·Filed 1995·Granted Dec 9, 1997·15 cites·9 claims
- 1560US5688802ABornyl xanthine derivatives with adenosine-antagonistic activityBOEHRINGER INGELHEIM KG·Filed 1996·Granted Nov 18, 1997·10 cites·3 claims
- 1659US6355652B1Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Mar 12, 2002·1 cites·14 claims
- 1756US4762832AMorpholine containing pyrrolidinones pharmaceutical compositions and useBOEHRINGER INGELHEIM KG·Filed 1986·Granted Aug 9, 1988·5 cites·5 claims
- 1848US6387921B1Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted May 14, 2002·0 cites·12 claims
- 1940US6683089B2N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-olsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jan 27, 2004·0 cites·10 claims
- 2039US4857528ASubstituted pyrrolidinones, pharmaceutical compositions and useBOEHRINGER INGELHEIM KG·Filed 1988·Granted Aug 15, 1989·1 cites·7 claims
- 2133US4891378ANortropanyl containing pyrrolidinones, pharmaceutical compositions and useBOEHRINGER SOHN INGELHEIM·Filed 1989·Granted Jan 2, 1990·0 cites·5 claims
- 2232US5614516A12-aminopyridazinopyrroloisoquinoline compoundsBOEHRINGER SOHN INGELHEIM·Filed 1995·Granted Mar 25, 1997·1 cites·8 claims
- 2330US5422353ATetrahydropyridine derivativesBOEHRINGER INGELHEIM KG·Filed 1993·Granted Jun 6, 1995·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Helmut Ensinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →